Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Mise à jour : Il y a 4 ans
Référence : NCT00928317

Femme et Homme

Extrait

The purpose of this clinical trial is to assess the safety, efficacy, tolerability, immunogenicity and pharmacokinetics of 3 dose levels of ART621 in the treatment of rheumatoid arthritis.


Critère d'inclusion

  • Rheumatoid Arthritis


Liens